Study objectives: To determine whether long-term treatment with exercise therapy results in more favorable, disease-specific, health-related quality of life (HRQL) compared with short-term treatment with exercise therapy; and to determine whether there are gender differences in disease-specific HRQL among individuals randomized into the two treatment groups. Design: Randomized clinical trial. Setting: Center-based exercise therapy unit at a university. Participants: One hundred forty patients with COPD; 118 completed trial. Interventions: Short-term exercise therapy (3 months); long-term exercise therapy (18 months). Measurements: Chronic Disease Respiratory Questionnaire (CRQ). Results: After 3 months of treatment, there were significant improvements in all CRQ scores for men and women (p < 0.01), and for the total sample (p < 0.01). At 18 months, individuals randomized into the long-term group had significantly more favorable scores than the short-term group for dyspnea (p ‫؍‬ 0.03), fatigue (p < 0.01), emotional function (p ‫؍‬ 0.04), and mastery (p ‫؍‬ 0.04). However, these effects were moderated by gender. That is, men in the long-term group reported significantly more favorable scores than men in the short-term group for dyspnea (0.04), fatigue (p < 0.001), emotional function (p ‫؍‬ 0.02), and mastery (p ‫؍‬ 0.02). At the 18-month assessment, there were no differences between long-term and short-term exercise therapy for women on any of the subscales of the CRQ. Conclusions: Taken collectively, the CRQ data demonstrate that long-term exercise therapy has little added benefit for women over short-term exercise therapy; however, men derive significant benefits from extended training.
C
OPD is characterized by a progressive and insidious chronic airway obstruction that produces shortness of breath. This relentless disease is the fourth-leading cause of death in the United States and is a major contributing factor to the high prevalence of morbidity and disability found among older adults. 1 Because there is no cure for this disease, an important focus of clinical medicine has been the prevention of further decline in physical function and the enhancement of health-related quality of life (HRQL). In this regard, two meta-analytic reviews have concluded that pulmonary rehabilitation (PR), which relies heavily on exercise therapy, has favorable effects on patients' HRQL. 2, 3 However, much of existing research on PR has focused on short-term exercise training and does not permit investigators to disentangle the effects of exercise from other interventions that often occur as a part of comprehensive PR. In addition, since most research has been conducted on men, little is known about the effects of exercise therapy on women. The current investigation was designed to address these shortcomings.
Cambach et al, 3 in their meta-analysis of 18 PR studies conducted from 1977 to 1997, reported on 11 randomized controlled trials (RCTs) that involved both exercise therapy and some quality-of-life measures. 3 In nearly half of these 11 RCTs (5 of the 11 studies conducted since 1987), the outcome measure of choice had been one or more domains of the Chronic Respiratory Disease Questionnaire (CRQ), developed by Guyatt and his colleagues in 1987. 4 Taken collectively, the meta-analysis by Cambach et al 3 concluded that PR resulted in significant summary effect sizes for all domains of the CRQ. Moreover, the authors demonstrated that improvements recorded on the CRQ were more favorable for patients who received exercise therapy as part of their PR.
Despite empirical evidence in support of the positive effects that physical rehabilitation has on the HRQL of patients with COPD, 2, 3, 5 there are a number of limitations in this body of research. For example, in the review by Cambach et al, 3 11 of the 14 RCTs reviewed had interventions that lasted 3 months, and 7 of the 11 RCTs that included exercise therapy and a measure of HRQL were characterized by small sample sizes (ie, Ͻ 40 subjects). In addition, 8 of the RCTs involving exercise therapy and HRQL also involved other components of PR, such as breathing exercises, social support, and relaxation training. Finally, as mentioned earlier, very little attention has been given to the study of women. For example, only 1 of the 14 trials 6 examined in the meta-analysis by Lacasse et al 2 included an equal number of male and female participants. Furthermore, in this latter study, there were no analyses reported for gender differences among participants. Additionally, in 13 of the 14 trials reviewed by Lacasse et al, 2 Ͻ 15% of the participants studied were women. Given the strong evidence in the cardiovascular disease literature that supports the scientific study of gender differences, 7, 8 it seems appropriate to consider gender as a potential moderator variable within the context of outcome research in PR.
With these issues in mind, the current study was designed to monitor changes in the CRQ that occur when patients with COPD exercise in structured group settings for either 3 months or 18 months. The study sample was large and included a good representation of both men and women. This latter feature of the sampling scheme enabled us to evaluate the potential moderating effect of gender on any observed effects that exercise has a disease-specific measure of HRQL.
Materials and Methods

Patients
Patients for this study were recruited from the Triad region of North Carolina, within a 50-mile radius of Wake Forest University. Recruitment strategies consisted of mass mailings, mass media advertisements, and requests from local physicians targeting age-eligible older adults with COPD. The final sample consisted of 78 men and 62 women Ͼ 50 years old. A diagram that describes the recruitment yield and trial adherence can be found in Figure 1 . All participants met the following inclusion criteria: (1) either disability associated with shortness of breath or diagnosis of chronic bronchitis and/or emphysema; (2) ambulatory; (3) between the ages of 55 years and 80 years old; (4) an expiratory airflow limitation such that the FEV 1 /FVC was Ͻ 70% and the FEV 1 was Ͼ 20% of predicted measure; and (5) not actively engaging in regular exercise or PR for the preceding 6 months. Exclusion criteria included concurrent history of: (1) active treatment for cancer; (2) severe congestive heart failure; (3) stroke; (4) peripheral vascular disease; (5) coronary artery disease; (6) valvular heart disease; (7) major psychiatric disease; (8) severe anemia; (9) liver or renal disease; (10) uncontrolled diabetes or hypertension; (11) orthopedic impairment; (12) blindness or deafness; (13) inability to perform exercise due to physical disability or positive exercise stress test; (14) cognitive impairment; and (15) alcohol consumption of greater than two drinks per day for the proceeding 2 months. Demographic and biometric characteristics of the participants are discussed in the "Results" section ( Table 1) .
Measures
CRQ:
The CRQ was employed as a disease-specific measure of HRQL. 4 This measure has been used extensively in the study of patients with COPD, and its reliability, validity, and sensitivity to change have been established. 3 The CRQ consists of four separate domains: dyspnea, fatigue, emotional function, and mastery. As suggested (G.H. Guyatt, MD; personal communication, May 20, 1997), scores were computed as the average response of the total number of items in each domain. Thus, the score for each domain could range from 1 (worst function) to 7 (best function).
Attendance: Attendance to the structured exercise therapy sessions was recorded for each participant in the study. Percent of compliance for attendance was defined as the number of sessions that the participant attended, divided by the number of sessions offered at the center, multiplied by 100. For example, if a participant attended 18 sessions of 36 offered, her percent compliance would be (18/36)ϫ100, or 50%. In addition, an average exercise intensity was calculated for each participant and was expressed as a percentage of peak heart rate.
Percentage of Peak Heart Rate: Percentage of peak heart rate achieved during a symptom-limited, graded exercise test was defined according to the following formula: THRR ϭ [(SLMHR-RHR)ϫdesired percentage] ϩ RHR. In this formula, THRR ϭ training heart rate range, SLMHR ϭ symptom-limited maximum heart rate achieved during the graded exercise test, and RHR ϭ resting heart rate. The average compliance for exercise intensity was determined by aggregating data across the total number of sessions completed by each participant. During the exercise therapy, heart rates were recorded by using a pulse oximeter (model AD-1000; Armstrong Medical; Lincolnshire, IL). Accuracy for heart rate measurement was Ϯ 2%, and averaging was done over an 8-s interval.
Procedures
Prior to participation in the intervention, patients visited the laboratory on three separate occasions for preliminary screening tests, baseline assessments, and completion of an informed consent. Once participants qualified for participation in the trial, they then engaged in 3 months of exercise therapy. At the end of this period, participants were tested for a second time and then randomized into either the short-term treatment or long-term treatment groups. Those patients randomized into short-term treatment no longer continued involvement in structured exercise therapy, whereas those assigned to long-term treatment continued exercise training for an additional 15 months. Participants assigned to short-term treatment were encouraged to engage in independent, unmonitored, home-based exercise. An additional assessment was taken 15 months after the randomization. Therefore, we report data from the baseline, 3-month, and 18-month assessments.
Exercise Therapy Intervention
Both the short-term and long-term interventions consisted of center-based training that included both walking and upper-body strength training conducted 3 times each week. Each session consisted of four phases: a warm-up (5 min), an aerobic stimulus phase (30 to 35 min), an upper-extremity strength training phase (15 to 20 min), and a cool-down period (5 min). The warm-up phase consisted of slow walking and four calisthenic-type exercises: arm circles, trunk rotations, shoulder and chest stretch, and side stretch. Participants were instructed to walk at a rating of perceived dyspnea of 3 to 4 (moderate to somewhat hard), based on the Borg 9 categorical scale. 10 Participants were encouraged to work for the entire 35 min within their THRR; however, individual adjustments were made depending on abilities to meet the exercise goals. The upper-extremity strength training program consisted of four gravity resistance exercises designed to increase strength in the muscles of the arms and the shoulder girdle. These exercises incorporated movements such as extension of the arms overhead, with the participant in a seated position, elbow flexion, horizontal flexion of the shoulder with the participant lying supine, as well as shoulder elevation and rotation. All exercises were performed using small hand weights. Participants were asked to perform two sets of 10 repetitions for each exercise, with a 1-min rest period between each set.
Statistical Analyses
The primary outcome measures of interest were the four domains of the CRQ scores. Changes in preintervention scores from baseline to 3 months, as well as treatment and gender differences at the 18-month assessment, were analyzed using analyses of covariance (adjusting for baseline CRQ scores, age, and %FEV 1 predicted). Analyses were conducted using the SAS statistical package (Procedure General Linear Model; SAS Institute; Cary, NC). Significance was set at the 0.05 level for all tests. All results are presented as adjusted means and SEM or as mean and SD.
Results
Demographic and medical information regarding the participants at the initial screening visit is shown in Table 1 . Inspection of these data reveals that the study sample was an older group of men and women who were overweight, relatively heterogeneous on income, and had mild-to-moderate disease. As expected, there were a number of comorbid conditions. For example, 41% of the participants in the short-term condition and 40% in the long-term condition had arthritis, and 41% of the participants in the short-term condition and 46% of individuals in the long-term condition had hypertension. Also, 39% of participants in the short-term condition and 34% of individuals in the long-term condition had heart disease. Table 2 provides data pertinent to compliance with the intervention partitioned by gender. Statistics are provided for the entire sample from months 0 to 3 and for those randomized to long-term therapy for months 3 to 18. Variables listed include percent attendance and average exercise intensity. Inspection of these data reveals that the participants were compliant with the prescription to the aerobic phase of exercise therapy. For example, participants who were randomized to the long-term and short-term conditions demonstrated comparable attendance to exercise sessions conducted at the center from baseline to 3 months. Furthermore, Table 2 demonstrates that there was no evidence for gender differences within the two conditions. Table 3 provides the means ( Ϯ SEM) that de- scribe how the various domains of the CRQ changed during the first 3 months of training prior to randomization. Data are included for the total sample as well as statistics for the subgroups of men and women. On examination of changes across time, it is evident that the patients in this trial experienced statistically and clinically significant changes for both dyspnea (effect size ϭ 0.60) and fatigue (effect size ϭ 0.48) during the first 3 months of treatment. Effect sizes were calculated by dividing the mean change over time by the pooled standard deviation. In addition, the emotional function and mastery scores were statistically significant and had effect sizes that were considered small (0.18 for emotional function and 0.22 for mastery). With the exception of dyspnea, for which women experienced greater improvements than men (p Ͻ 0.026), there was no evidence that 3 months of exercise therapy has differential effects on the HRQL of COPD patients as a function of gender.
After the first 3 months of training, patients were randomized to either short-term or long-term treatment. Recall that formal exercise therapy was terminated for the short-term group, whereas the longterm group continued for another 15 months. Table  4 provides the means ( Ϯ SEM) that permit a comparison of exercise therapy, either short-term or long-term, on patients' CRQ scores. Once again, data are presented for the total sample as well as for each gender. Whereas the raw scores are provided for descriptive purposes, statistical comparison of the short-term and long-term groups for both the total sample and each gender was conducted on adjusted means, which permitted us to control for differences in age, disease status, and baseline differences in CRQ scores. Inspection of the 18-month adjusted means for the total sample would indicate that long-term exercise training produced significantly more favorable effects for all of the domains of the CRQ than short-term exercise training. Once again, as with the baseline-to-3 months data, scores for emotional functioning were statistically significant, yet the differences were relatively small in magnitude. It is important to note, however, that examination of subgroup means for gender led to a very different conclusion. Specifically, the benefits of long-term exercise training compared with shortterm exercise training occurred only for men. Note that, at 18 months, the long-term fatigue score for men was higher than it was for women in this condition (⌬ ϭ 0.56). Similarly, for emotional function, the long-term mean was higher for men than women (⌬ ϭ 0.61).
Discussion
The primary objectives of this study were: (1) to contrast the effects of short-term vs long-term exercise therapy on the disease-specific HRQL of patients with COPD, and (2) to explore the potential moderating effect of gender on any observed differences betweenthe two treatments. During the first 3 months of exercise therapy, all participants experienced statistically significant improvements in their CRQ scores, a disease-specific index of HRQL. Interestingly, women reported more gains than men in the dyspnea (⌬ ϭ 0.85 vs ⌬ ϭ 0.49) and fatigue (⌬ ϭ 0.57 vs ⌬ ϭ 0.53) domains of the CRQ. Haggerty and colleagues 11 also reported gender differences among patients who participated in shortterm PR. However, in their study, effects were observed on the mastery and control subscales of the CRQ. It is difficult to resolve the differences between our data and that of Haggerty et al 11 because the latter study involved comprehensive PR, as opposed to exercise therapy alone. Also, the study by Haggerty et al 11 involved data from 10 different centers. The exercise therapy in these centers ranged from 1 to 3 days each week and lasted anywhere from 5 weeks to 12 weeks. Although this phase of our study design did not have a control group for comparison, our results are consistent with existing quantitative reviews of the short-term PR literature. 2, 3 One unexpected trend in these first 3 months of data concerns the failure of scores, on the emotional functioning and mastery domains of the CRQ, to approach a change of one half unit, an increment deemed by Lacasse and colleagues 2 to be clinically significant. One explanation for this pattern in the data is the fact that baseline scores for the emotional functioning and mastery domains were more than a full unit higher than scores for dyspnea and fatigue. In the study of psychological functioning, baseline scores commonly influence the degree of change observed with exercise interventions. 12 The randomized component of the current study, which involved a comparison of short-term (3 months) vs long-term (18 months) exercise therapy, produced statistically significant effects on all scores of the CRQ. In fact, the dyspnea scale approached clinical significance (⌬ ϭ 0.47), and the fatigue scale change was of a clinically relevant magnitude (⌬ ϭ 0.53). Although these differences favor longterm therapy, any interpretation of the differences between long-term vs short-term in the CRQ must be qualified by the moderating effect observed for gender. Specifically, examination of the adjusted 18-month CRQ data revealed that any advantage of long-term exercise therapy, compared with the short-term therapy condition, was due to benefits accrued by men and not women. The similarity in CRQ scores for women randomized to either shortterm or long-term exercise therapy was striking. The largest difference between these conditions was only one tenth of a unit for any of the CRQ domains, and the absolute scores were similar to men in short-term therapy. By contrast, men in the long-term group experienced an improvement in fatigue rate of 0.83 U and an enhancement in emotional function of 0.45 U compared with men in short-term therapy. Data concerning the mastery and dyspnea domains require additional discussion. Whereas men in the long-term condition received a clear benefit of 0.40 U in mastery compared with men in short-term therapy, there was no such effect for women. However, at 18 months, women in the short-term group reported the same level of mastery as women in the long-term group, an absolute value that was comparable to men in the long-term group. For some reason, women assigned to short-term therapy continued to improve their mastery scores for up to 18 months despite the lack of an active treatment program. Furthermore, it is interesting to recall that women made dramatic improvements in dyspnea scores during the first 3 months of treatment compared with men. These effects were not lost as a function of short-term exercise therapy. In fact, it took 18 months for men to improve their dyspnea scores to a level that was comparable to those of the women.
Taken collectively, the CRQ data demonstrate that long-term exercise therapy has little added benefit for women over short-term exercise therapy; however, men derive significant benefits from extended training. It is intriguing that women made more dramatic improvements in their dyspnea scores with 3 months of training than did men, whereas women appeared to be limited in their ability to enhance emotional functioning and mastery through exercise therapy alone. Although we cannot offer definitive explanations for these effects, several hypotheses come to mind. First, one might argue that, in the long-term condition, women didn't adhere to the exercise prescription as closely as did the men.
However, examination of data on the exercise attendance and intensity does not support such a hypothesis. Second, it is plausible that exercise alone is an insufficient form of rehabilitation for women. This could be tied to the fact that men value their physical function more than women do and thus derive more benefit from involvement in extended exercise therapy. In addition, drawing from the findings in cardiac rehabilitation literature, there is evidence to support the possibility that women may benefit more from rehabilitation that includes emotional support from staff members and social interaction, along with traditional exercise therapy. 13 In general, the current study suggests that future research should consider testing the independent effects of various components of comprehensive PR on HRQL and should take seriously the moderating effects of gender in both the design and analysis of subsequent intervention research.
